UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 479

Sortiert nach

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Thrombosis and haemostasis, 2017, Vol.117 (2), p.219

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis

Research and practice in thrombosis and haemostasis, 2020-10, Vol.4 (7), p.1178-1191

2020

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for prediction of venous thromboembolism in cancer

Blood, 2013-09, Vol.122 (12), p.2011-2018

2013

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers and venous thromboembolism

Arteriosclerosis, thrombosis, and vascular biology, 2009-03, Vol.29 (3), p.332

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Blood, 2021-03, Vol.137 (12), p.1669-1678

2021

Link zum Volltext

Verfügbarkeit prüfen

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2016-10, Vol.17 (10), p.e452-e466

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of venous thromboembolism in cancer patients

Blood, 2010-12, Vol.116 (24), p.5377-5382

2010

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated venous thromboembolism

Nature reviews. Disease primers, 2022-02, Vol.8 (1), p.11-11, Article 11

2022

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1819-1822

2021

Link zum Volltext

Verfügbarkeit prüfen

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2019-10, Vol.17 (10), p.1772-1778

2019

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy

Chest, 2008-06, Vol.133 (6), p.844S-886S

2008

Link zum Volltext

Verfügbarkeit prüfen

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

Scientific reports, 2021-06, Vol.11 (1), p.12967-12967, Article 12967

2021

Link zum Volltext

Verfügbarkeit prüfen

High D-dimer levels are associated with poor prognosis in cancer patients

Haematologica (Roma), 2012-08, Vol.97 (8), p.1158-1164

2012

Link zum Volltext

Verfügbarkeit prüfen

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Scientific reports, 2021-02, Vol.11 (1), p.3092-3092, Article 3092

2021

Link zum Volltext

Verfügbarkeit prüfen

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.550-561

2020

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2099-2103

2011

Link zum Volltext

Verfügbarkeit prüfen

Plasma Clot Properties in Patients with Pancreatic Cancer

Cancers, 2023-08, Vol.15 (16), p.4030

2023

Link zum Volltext

Verfügbarkeit prüfen

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

Nature genetics, 2009-04, Vol.41 (4), p.450-454

2009

Link zum Volltext

Verfügbarkeit prüfen

The role of podoplanin in cancer-associated thrombosis

Thrombosis research, 2018-04, Vol.164, p.S34-S39

2018

Link zum Volltext

Verfügbarkeit prüfen

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4124-4129

2009

Link zum Volltext

Verfügbarkeit prüfen

Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3870-3875

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.247-255

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Annals of hematology, 2020-12, Vol.99 (12), p.2763-2771

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients

Thrombosis research, 2012-04, Vol.129, p.S6-S9

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(467)
Mit Volltextzugriff
(418)

Publikationsform

Artikel
(474)
Buchkapitel
(3)
Berichte
(1)
Texte
(1)

Sprache

Englisch
(454)
Japanisch
(49)
Deutsch
(31)
Norwegisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(336)
Life Sciences & Biomedicine
(331)
Humans
(294)
Hematology
(240)
Female
(179)
Male
(168)
Middle Aged
(154)
Adult
(141)
Cardiovascular System & Cardiology
(128)
Peripheral Vascular Disease
(124)
Aged
(104)
Biological And Medical Sciences
(89)
Risk Factors
(89)
Medical Sciences
(84)
Venous Thromboembolism
(66)
Thrombosis
(54)
Prospective Studies
(53)
Adolescent
(48)
Cancer
(42)
Oncology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis

Biomarkers for prediction of venous thromboembolism in cancer

Biomarkers and venous thromboembolism

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

Prediction of venous thromboembolism in cancer patients

Cancer-associated venous thromboembolism

Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

High D-dimer levels are associated with poor prognosis in cancer patients

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

Plasma Clot Properties in Patients with Pancreatic Cancer

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

The role of podoplanin in cancer-associated thrombosis

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients

Suchergebnisse filtern